BSD SCIENCE

Oral Drug Delivery System for Controlled Release (CR) of Lipophilic Drugs

Health Tech & Life Sciences
Active
Pre-Funding Tel Aviv-Yafo, Israel Founded 2022
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2022
Headcount
2
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

BSD SCIENCE is a biotech company that has developed a unique oral dosage form designed for controlled release (CR) of lipophilic drugs, in order to achieve long duration of effect, less adverse effects and higher compliance to treatment.

The platform is suitable for lipophilic molecules used in the Medical Cannabis, Pharma industry and Dietary Supplement markets. During 2022, the company completed a POC PK animals study, where promising results were achieved, and U.S. Provisional Patent Application was submitted. BSD SCIENCE plans to move on towards human PK study.

Q&A

What is BSD SCIENCE's primary focus?
BSD SCIENCE is a biotech company specializing in an oral drug delivery system for the controlled release of lipophilic drugs.
When was BSD SCIENCE founded?
BSD SCIENCE was founded in January 2022.
What markets does BSD SCIENCE's platform target?
The platform is suitable for lipophilic molecules used in the Medical Cannabis, Pharma industry, and Dietary Supplement markets.
What was a key development for BSD SCIENCE in 2022?
In 2022, BSD SCIENCE completed a POC PK animal study with promising results and submitted a U.S. Provisional Patent Application.
What are BSD SCIENCE's future plans regarding clinical studies?
BSD SCIENCE plans to move towards a human PK study.
How many employees does BSD SCIENCE currently have?
BSD SCIENCE has 1-10 employees.
What is the current funding stage of BSD SCIENCE?
BSD SCIENCE is currently in the Pre-Funding stage.
Where is BSD SCIENCE headquartered?
BSD SCIENCE is headquartered in Tel Aviv-Yafo, Israel.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

Verified

Tags

pharmaceuticalsbiotechnologydrug-deliverytreatmentsmedical-cannabis
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)